-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
The National Osteoporosis Foundation Remembers Prof. Pierre Delmas
Washington, DC (July 24, 2008) – The National Osteoporosis Foundation (NOF) mourns the passing of Pierre D. Delmas, M.D., Ph.D. of Lyon, France. Prof. Delmas was an internationally recognized expert in the areas of osteoporosis and metabolic bone disease. He authored more than 400 articles, reviews and chapters in international scientific journals and textbooks. Dr. Delmas served as founding president of the International Osteoporosis Foundation (IOF), for which he initiated numerous global educational, clinical and research programs on osteoporosis.
“My dear friend and esteemed colleague advanced so many areas of research into osteoporosis and metabolic bone disease ” said Dr. Lindsay. “He leaves as a legacy multiple advances into the causes, risk factors and treatment of osteoporosis. His dedication to the field will be remembered for years to come.”
Dr. Lindsay served with Dr. Delmas as editors-in-chief of Osteoporosis International, a scientific publication co-published by NOF and IOF.
“His leadership of IOF improved the lives of osteoporosis patients throughout the world,” said Ethel Siris, M.D., immediate past president of NOF and fellow IOF Board Member. “We will miss him greatly.”
###
Established in 1984, the National Osteoporosis Foundation is the nation’s leading voluntary health organization solely dedicated to osteoporosis and bone health. Our mission is to prevent osteoporosis, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis and related fractures, and to find a cure. For more information on osteoporosis and bone health, contact NOF online at www.nof.org or by telephone (800) 223-9994.
The latest
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
Explore by tag
